ADAM17 and colorectal carcinoma: Compared with normal colonic mucosa, ADAM17 is overexpressed in primary and metastatic CRC tissues, and a selective ADAM17 inhibitor leads to concentration-dependent decreases in cell proliferation and activity [143].